Molecular biology, Biochemistry, Cytochrome P450, Pharmacology and CYP2A6 are her primary areas of study. Her Molecular biology study combines topics from a wide range of disciplines, such as Luciferase, Three prime untranslated region, Messenger RNA, microRNA and Regulation of gene expression. Her Cytochrome P450 research includes elements of Metabolite, Isozyme and In vivo.
Her work is dedicated to discovering how Pharmacology, CYP2B6 are connected with Enzyme inhibitor and Drug interaction and other disciplines. Her CYP2A6 research is multidisciplinary, relying on both Estrogen-related receptor alpha and Nicotine. Her Nicotine study integrates concerns from other disciplines, such as Pharmacogenetics and Allele, Allele frequency.
Miki Nakajima mainly investigates Pharmacology, Biochemistry, Molecular biology, Microsome and Cytochrome P450. Her Pharmacology research incorporates elements of Hydrolase and Nicotine. Her works in Enzyme, Metabolite, Drug metabolism, Metabolism and Isozyme are all subjects of inquiry into Biochemistry.
The study incorporates disciplines such as Luciferase and Regulation of gene expression, Messenger RNA, Gene, microRNA in addition to Molecular biology. She has researched Microsome in several fields, including Endocrinology, Carboxylesterase and Internal medicine. Her Cytochrome P450 study frequently involves adjacent topics like In vivo.
Her primary areas of study are microRNA, Pharmacology, Biochemistry, Molecular biology and RNA editing. The microRNA study combines topics in areas such as Post-transcriptional regulation, Luciferase, HEK 293 cells, Toxicity and Single-nucleotide polymorphism. Her biological study spans a wide range of topics, including Microsome, Cytochrome P450 and Enzyme.
Hydrolase is closely connected to Carboxylesterase in her research, which is encompassed under the umbrella topic of Microsome. Her research is interdisciplinary, bridging the disciplines of Function and Biochemistry. Her Xenobiotic research focuses on Gene and how it relates to CYP2A6.
Her primary scientific interests are in microRNA, Molecular biology, Biochemistry, Enzyme and Microsome. Her microRNA research integrates issues from ADAR, Bioinformatics, Post-transcriptional regulation, Luciferase and Untranslated region. Her research integrates issues of Gene knockdown, RNA, RNA editing, Messenger RNA and HEK 293 cells in her study of Molecular biology.
Her biological study deals with issues like CYP2A6, which deal with fields such as Gene. Her study in Biochemistry is interdisciplinary in nature, drawing from both Adduct and Drug development. Her studies in Microsome integrate themes in fields like Hydrolase, Carboxylesterase and Pharmacology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Cytochrome P450-mediated metabolism of estrogens and its regulation in human
Yuki Tsuchiya;Miki Nakajima;Tsuyoshi Yokoi.
Cancer Letters (2005)
MicroRNA Regulates the Expression of Human Cytochrome P450 1B1
Yuki Tsuchiya;Miki Nakajima;Shingo Takagi;Takao Taniya.
Cancer Research (2006)
Genetic polymorphisms of human organic anion transporters OATP-C (SLC21A6) and OATP-B (SLC21A9): allele frequencies in the Japanese population and functional analysis.
Takashi Nozawa;Miki Nakajima;Ikumi Tamai;Kumiko Noda.
Journal of Pharmacology and Experimental Therapeutics (2002)
Post-transcriptional Regulation of Human Pregnane X Receptor by Micro-RNA Affects the Expression of Cytochrome P450 3A4
Shingo Takagi;Miki Nakajima;Takuya Mohri;Tsuyoshi Yokoi.
Journal of Biological Chemistry (2008)
Expression of UGT1A and UGT2B mRNA in human normal tissues and various cell lines.
Akiko Nakamura;Miki Nakajima;Hiroyuki Yamanaka;Ryoichi Fujiwara.
Drug Metabolism and Disposition (2008)
Human CYP1B1 Is Regulated by Estradiol via Estrogen Receptor
Yuki Tsuchiya;Miki Nakajima;Satoru Kyo;Taro Kanaya.
Cancer Research (2004)
Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli.
Hiroshi Yamazaki;Mami Nakamura;Tomoko Komatsu;Katsuhiro Ohyama.
Protein Expression and Purification (2002)
Quantitative analysis of UDP-glucuronosyltransferase (UGT) 1A and UGT2B expression levels in human livers.
Takeshi Izukawa;Miki Nakajima;Ryoichi Fujiwara;Hiroyuki Yamanaka.
Drug Metabolism and Disposition (2009)
Inhibitory effects of amiodarone and its N‐deethylated metabolite on human cytochrome P450 activities: Prediction of in vivo drug interactions
K. Ohyama;M. Nakajima;M. Suzuki;N. Shimada.
British Journal of Clinical Pharmacology (2000)
MicroRNA regulates human vitamin D receptor.
Takuya Mohri;Miki Nakajima;Shingo Takagi;Sayaka Komagata.
International Journal of Cancer (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Nagoya University
Showa Pharmaceutical University
University of Tokushima
Intermountain Healthcare
Osaka City University
Kanazawa University
Vanderbilt University
National Institutes of Health
Kanazawa University
Vanderbilt University
New York University
Wright-Patterson Air Force Base
Durham University
Eindhoven University of Technology
Georgia Institute of Technology
Max Planck Society
University of Maryland, College Park
Technical University of Munich
German Cancer Research Center
International Trademark Association
Technical University of Denmark
Palacký University, Olomouc
United States Geological Survey
University of Natural Resources and Life Sciences
King Saud University
University of Guelph